Pharmacological management of allergic rhinitis: MSAI issues consensus statement Medha Baranwal20 Aug 2022 11:00 AM ISTMalaysia: The Malaysian Society of Allergy and Immunology has released a consensus statement on the pharmacological management of allergic rhinitis...
Improvement in quality of Life after management of Allergic Rhinitis Dr. Nandita Mohan4 Aug 2022 11:00 AM ISTAllergic rhinitis (AR) is associated with disturbed sleep and subsequent functioning, and an impaired quality of life (QoL). The symptoms of...
Allergic rhinitis-an overview on treatment recommendations and current guidelines Dr. Kamal Kant Kohli22 July 2022 11:49 AM ISTRegarded to be an Ig-E mediated inflammatory disorder, most commonly affecting the nasal mucosa and its associated structures, Allergic Rhinitis (AR)...
Allergen Immunotherapy safe and effective therapy for allergic Rhinitis with Rheumatic Autoimmune Disease Dr.Niharika Harsha B14 July 2022 9:30 AM ISTAllergen Immunotherapy was found to be a safe and effective treatment modality in patients with allergic rhinitis complicated by Rheumatic Autoimmune...
Infographic: Allergic Rhinitis-Quick Overview of Treatment Algorithm Dr. Kamal Kant Kohli11 July 2022 12:45 PM IST.single-featured{display:none;}Allergic rhinitis (AR), an inflammatory illness of the upper respiratory tract, is now being acknowledged as a global...
FDA clears barrier nasal spray for mild allergic rhinitis Dr. Kamal Kant Kohli30 Jun 2022 9:00 AM ISTThe Food and Drug Administration (FDA) has cleared Bentrio nasal spray ("Bentrio Allergy Blocker") for treatment of allergic rhinitis. The nasal...
Management of Allergic Rhinitis during COVID-19 Pandemic Dr. Kamal Kant Kohli27 Jun 2022 12:00 PM ISTThe COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) has challenged the healthcare systems and altered the...
Decoding the correct diagnosis of Allergic Rhinitis in clinic practice - Dr Tushar Kanti Ghosh DR. TUSHAR KANTI GHOSH21 Jun 2022 12:45 PM IST Advertisement Allergic rhinitis is an Immunoglobulin E (IgE)-mediated disorder of the nose, usually caused by sensitization...
Managing co-existing allergic rhinitis and asthma: Analyzing the role of Montelukast-levocetirizine combination Dr. Kamal Kant Kohli13 Jun 2022 12:41 PM ISTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
Novel therapies in managing Allergic rhinitis: How far have we come? Dr. Kamal Kant Kohli8 Jun 2022 12:45 PM ISTAllergic rhinitis(AR) is a common respiratory condition affecting 40 % of the worldwide population. Due to its shared pathophysiology with...
Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection Dr. Kamal Kant Kohli19 May 2022 12:54 PM ISTThe spiking frequency of allergic respiratory illness over the last several decades, and the increasing rate of air pollution owing to urbanization,...
Analyzing the efficacy and safety of leukotriene receptor antagonists in the management of allergic rhinitis Dr. Kamal Kant Kohli29 April 2022 12:00 PM ISTAllergic Rhinitis (AR) is an inflammatory illness of the upper respiratory tract, with sneezing, itching, nasal congestion, and rhinorrhea as the most...
